Immunogenicity and Efficacy inAotusMonkeys of Four RecombinantPlasmodium falciparumVaccines in Multiple Adjuvant Formulations Based on the 19-Kilodalton C Terminus of Merozoite Surface Protein 1
Open Access
- 1 April 2000
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 68 (4) , 2215-2223
- https://doi.org/10.1128/iai.68.4.2215-2223.2000
Abstract
The immunogenicity and protective efficacy of four versions of recombinant C-terminal 19-kDa epidermal growth factor-like region of the major surface protein 1 (rMSP119) ofPlasmodium falciparumwas studied inAotusmonkeys. Vaccination with each of the four rMSP119constructs elicited high levels of antibodies to MSP119but only one construct, the 19-kDa fragment expressed as a secreted fusion protein fromSaccharomyces cerevisiae(yP30P2MSP119), induced a high degree of protective immunity inAotus nancymaiagainst lethalP. falciparumchallenge. Protective formulation required Freund's adjuvant; vaccination with yP30P2MSP119in six other adjuvants that are suitable for human use induced lower levels of antibody response and no protection. These results emphasize the need to continue the search for an adjuvant that is comparable to Freund's adjuvant in potency and is safe for use in humans.Keywords
This publication has 23 references indexed in Scilit:
- Vaccine Efficacy of RecombinantPlasmodium falciparumMerozoite Surface Protein 1 in Malaria-Naive, -Exposed, and/or -RechallengedAotus vociferansMonkeysInfection and Immunity, 2000
- Antibodies that Inhibit Malaria Merozoite Surface Protein–1 Processing and Erythrocyte Invasion Are Blocked by Naturally Acquired Human AntibodiesThe Journal of Experimental Medicine, 1997
- Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein.The Journal of Experimental Medicine, 1994
- Production, Purification and Immunogenicity of a Malaria Transmission-Blocking Vaccine Candidate: TBV25H Expressed in Yeast and Purified Using Nickel-NTA AgaroseBio/Technology, 1994
- Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded proteinMolecular and Biochemical Parasitology, 1994
- Expression and antigenicity of Plasmodium falciparum major merozoite surface protein (MSP119) variants secreted from Saccharomyces cerevisiaeMolecular and Biochemical Parasitology, 1994
- Immunization against malaria with a recombinant proteinParasite Immunology, 1994
- Processing of thePlasmodium falciparum major merozoite surface protein-1: identification of a 33-kilodalton secondary processing product which is shed prior to erythrocyte invasionMolecular and Biochemical Parasitology, 1991
- A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.The Journal of Experimental Medicine, 1990
- Immunization against blood-stage rodent malaria using purified parasite antigensNature, 1981